307 related articles for article (PubMed ID: 36534467)
21. Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response.
Butters C; Benede N; Moyo-Gwete T; Richardson SI; Rohlwink U; Shey M; Ayres F; Manamela NP; Makhado Z; Balla SR; Madzivhandila M; Ngomti A; Baguma R; Facey-Thomas H; Spracklen TF; Day J; van der Ross H; Riou C; Burgers WA; Scott C; Zühlke L; Moore PL; Keeton RS; Webb K
Clin Immunol; 2024 Feb; 259():109877. PubMed ID: 38141746
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Antibody Titers and Severity of Multisystem Inflammatory Syndrome in Children.
Kurtca M; Chokkalla AK; Devaraj S
Ann Clin Lab Sci; 2023 May; 53(3):360-365. PubMed ID: 37437945
[TBL] [Abstract][Full Text] [Related]
23. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
[TBL] [Abstract][Full Text] [Related]
24. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers.
Seery V; Raiden SC; Algieri SC; Grisolía NA; Filippo D; De Carli N; Di Lalla S; Cairoli H; Chiolo MJ; Meregalli CN; Gimenez LI; Gregorio G; Sarli M; Alcalde AL; Davenport C; Bruera MJ; Simaz N; Pérez MF; Nivela V; Bayle C; Tuccillo P; Agosta MT; Pérez H; Villa Nova S; Suárez P; Takata EM; García M; Lattner J; Rolón MJ; Coll P; Sananez I; Holgado MP; Ferrero F; Geffner J; Arruvito L;
EBioMedicine; 2021 May; 67():103357. PubMed ID: 33979758
[TBL] [Abstract][Full Text] [Related]
25. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.
Deakin CT; Cornish GH; Ng KW; Faulkner N; Bolland W; Hope J; Rosa A; Harvey R; Hussain S; Earl C; Jebson BR; Wilkinson MGLL; Marshall LR; O'Brien K; Rosser EC; Radziszewska A; Peckham H; Patel H; Heaney J; Rickman H; Paraskevopoulou S; Houlihan CF; Spyer MJ; Gamblin SJ; McCauley J; Nastouli E; Levin M; Cherepanov P; Ciurtin C; Wedderburn LR; Kassiotis G
Med; 2021 Sep; 2(9):1093-1109.e6. PubMed ID: 34414384
[TBL] [Abstract][Full Text] [Related]
26. Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay.
Sigal GB; Novak T; Mathew A; Chou J; Zhang Y; Manjula N; Bathala P; Joe J; Padmanabhan N; Romero D; Allegri-Machado G; Joerger J; Loftis LL; Schwartz SP; Walker TC; Fitzgerald JC; Tarquinio KM; Zinter MS; Schuster JE; Halasa NB; Cullimore ML; Maddux AB; Staat MA; Irby K; Flori HR; Coates BM; Crandall H; Gertz SJ; Randolph AG; Pollock NR;
Clin Infect Dis; 2022 Oct; 75(8):1351-1358. PubMed ID: 35213684
[TBL] [Abstract][Full Text] [Related]
27. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children.
Lam KP; Chiñas M; Julé AM; Taylor M; Ohashi M; Benamar M; Crestani E; Son MBF; Chou J; Gebhart C; Chatila T; Newburger J; Randolph A; Gutierrez-Arcelus M; Henderson LA
Clin Immunol; 2022 Oct; 243():109106. PubMed ID: 36049601
[TBL] [Abstract][Full Text] [Related]
29. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
[TBL] [Abstract][Full Text] [Related]
30. Zonulin and claudin-5 levels in multisystem inflammatory syndrome and SARS-CoV-2 infection in children.
Kılıç AO; Akın F; Yazar A; Metin Akcan Ö; Topcu C; Aydın O
J Paediatr Child Health; 2022 Sep; 58(9):1561-1565. PubMed ID: 35638118
[TBL] [Abstract][Full Text] [Related]
31. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
33. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
Front Immunol; 2021; 12():793953. PubMed ID: 34899762
[TBL] [Abstract][Full Text] [Related]
34. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
Front Immunol; 2021; 12():786554. PubMed ID: 35003104
[TBL] [Abstract][Full Text] [Related]
35. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
[TBL] [Abstract][Full Text] [Related]
36. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
[TBL] [Abstract][Full Text] [Related]
37. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
[TBL] [Abstract][Full Text] [Related]
38. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
Chansaenroj J; Yorsaeng R; Puenpa J; Wanlapakorn N; Chirathaworn C; Sudhinaraset N; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Ayuthaya TPN; Brukesawan C; Intharasongkroh D; Chaiwanichsiri D; Issarasongkhram M; Kitphati R; Mungaomklang A; Thitithanyanont A; Nagavajara P; Poovorawan Y
PLoS One; 2022; 17(4):e0267102. PubMed ID: 35446889
[TBL] [Abstract][Full Text] [Related]
39. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
[TBL] [Abstract][Full Text] [Related]
40. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients.
Staats LAN; Pfeiffer H; Knopf J; Lindemann A; Fürst J; Kremer AE; Hackstein H; Neurath MF; Muñoz LE; Achenbach S; Leppkes M; Herrmann M; Schett G; Steffen U
Cells; 2020 Dec; 9(12):. PubMed ID: 33322797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
